Bioequivalence Study of Pimavanserin 34 mg Capsule

Clinical trial NCT06450184 · COMPLETED

Trial details

NCT number: NCT06450184
Sponsor: Humanis Saglık Anonim Sirketi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease Psychosis

Start date: 2024-01-11
Primary completion: 2024-01-17
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.